These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1976899)

  • 1. Washing with 8 mol/l urea to correct false-positive anti-HCV results.
    Goeser T; Blazek M; Gmelin K; Kommerell B; Theilmann L
    Lancet; 1990 Oct; 336(8719):878. PubMed ID: 1976899
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of ELISA cut-off reduces HCV-Ab false-positivity in patients with HBV, HDV and alcoholic liver disease.
    Andreone P; Cursaro C; Miniero R; Stefanini GF; Sprovieri G; Gasbarrini G
    Ital J Gastroenterol; 1991 Dec; 23(9):567-8. PubMed ID: 1662091
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-hepatitis C virus antibodies in monoclonal gammopathy: an appraisal using the second generation tests.
    Marson P; Vicarioto M; De Silvestro G; Tenderini ML; Nardo G; Ongaro G
    Haematologica; 1992; 77(2):188. PubMed ID: 1328000
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-hepatitis C virus antibodies in primary Sjögren's syndrome: false positive results are related to hyper-gamma-globulinaemia.
    Vitali C; Sciuto M; Neri R; Greco F; Mavridis AK; Tsioufas AG; Tsianos EV
    Clin Exp Rheumatol; 1992; 10(1):103-4. PubMed ID: 1312919
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis of hepatitis C virus infection].
    Mateos M; Teruel JL; Nash R; Fernández Lucas M
    Enferm Infecc Microbiol Clin; 1991 Dec; 9(10):662. PubMed ID: 1668299
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation between ELISA and recombinant immunoblot assay in serum samples positive for anti-HCV.
    Lin HH; Hsu HY; Chang MH; Wang JT; Chen PJ; Chen DS
    J Formos Med Assoc; 1992 Jul; 91(7):729-30. PubMed ID: 1360305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of HCV-ELISA using synthetic peptide].
    Takahashi T; Hayashi N; Shikata T
    Nihon Rinsho; 1991 Feb; 49(2):347-50. PubMed ID: 1849192
    [No Abstract]   [Full Text] [Related]  

  • 8. False-positive anti-HCV in biliary cirrhosis.
    Housset C; Hirschauer C; Degos F
    Ann Intern Med; 1991 Feb; 114(3):252. PubMed ID: 1845839
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-hepatitis C virus serology in primary Sjögren's syndrome: no evidence of cross-reactivity between rheumatoid factor and specific viral proteins.
    Marson P; Ostuni PA; Vicarioto M; Ongaro G; Gambari PF
    Clin Exp Rheumatol; 1991; 9(6):661-2. PubMed ID: 1662569
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity.
    Lenzi M; Johnson PJ; McFarlane IG; Ballardini G; Smith HM; McFarlane BM; Bridger C; Vergani D; Bianchi FB; Williams R
    Lancet; 1991 Aug; 338(8762):277-80. PubMed ID: 1677111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of antibodies to hepatitis C virus in alcoholic cirrhosis: fact or fiction?
    Bode JC; Biermann J; Kohse KP; Walker S; Bode C
    Alcohol Alcohol; 1991; 26(2):111-4. PubMed ID: 1652249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liatek HCV: the six-antigen test for confirmation of the presence of anti-HCV antibodies].
    Juszczyk J; Flieger J; Migdalski P; Skalisz H
    Przegl Epidemiol; 1992; 46(1-2):11-7. PubMed ID: 1282266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False positive reaction of heat-inactivated sera in enzyme-linked immunosorbent assay for antibody to hepatitis C virus.
    Yoshida H; Ishikawa H; Honda S; Miura Y; Ogata M
    Fukushima J Med Sci; 1992 Jun; 38(1):35-41. PubMed ID: 1284049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus (HCV) antibodies in the rheumatic diseases.
    Tanaka M; Kobayashi S; Tajima M; Hatta S; Isobe Y; Hashimoto H; Hirose S
    Clin Exp Rheumatol; 1991; 9(3):308-9. PubMed ID: 1652389
    [No Abstract]   [Full Text] [Related]  

  • 15. Significance of "borderline" reactivity in tests for antibody to hepatitis C virus in blood donors.
    Belloni M; Alghisi A; Ferrazzi F; Diamantini A; Chemello L; Alberti A
    Transfusion; 1991 Oct; 31(8):781-2. PubMed ID: 1656556
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-HCV-screening of blood donors in Gothenburg--the second generation tests are more specific].
    Lindholm A; Shev S; Norkrans G; Iwarson S; Hermodsson S
    Lakartidningen; 1991 Oct; 88(42):3475-6. PubMed ID: 1658502
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-HCV seroprevalence in pregnant women in France.
    Roudot-Thoraval F; Pawlotsky JM; Deforges L; Girollet PP; Dhumeaux D
    Gut; 1993; 34(2 Suppl):S55-6. PubMed ID: 7686117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-generation RIBA to confirm diagnosis of HCV infection.
    Lancet; 1991 Apr; 337(8746):912-3. PubMed ID: 1672986
    [No Abstract]   [Full Text] [Related]  

  • 19. Low cost anti-HCV screening of blood donors.
    Neill AG; Conradie JD
    Lancet; 1992 Oct; 340(8827):1096. PubMed ID: 1357481
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of NS3 and NS5 antigens in screening for HCV antibody.
    Goffin E; Pirson Y; Cornu C; Jadoul M; van Ypersele de Strihou C
    Lancet; 1994 Apr; 343(8901):854. PubMed ID: 7511196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.